A phase 3 study of ATL1103 in patients with acromegaly

Trial Profile

A phase 3 study of ATL1103 in patients with acromegaly

Planning
Phase of Trial: Phase III

Latest Information Update: 10 Sep 2015

At a glance

  • Drugs Atesidorsen (Primary)
  • Indications Acromegaly
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Sep 2015 New trial record
    • 09 Sep 2015 According to Antisense Therapeutics media release, company is planning for a pre-IND meeting with the FDA in the second half of 2015 to discuss about the requirements to initiate this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top